综述 |
|
|
|
|
基于基因敲除的炎性肠疾病复合动物模型研究进展 |
赵慧慧( ),汤慧芳*( ) |
浙江大学医学院, 浙江 杭州 310058 |
|
Research progress on composite animal models of inflammatory bowel disease based on gene knockout |
ZHAO Huihui( ),TANG Huifang*( ) |
Zhejiang University School of Medicine, Hangzhou 310058, China |
1 |
ZHANG Y Z , LI Y Y . Inflammatory bowel disease:pathogenesis[J]. World J Gastroenterol, 2014, 20 (1): 91- 99
doi: 10.3748/wjg.v20.i1.91
|
2 |
MIZOGUCHI A . Animal models of inflammatory bowel disease[J]. Prog Mol Biol Transl Sci, 2012, 105:263- 320
doi: 10.1016/B978-0-12-394596-9.00009-3
|
3 |
KHOR B , GARDET A , XAVIER R J . Genetics and pathogenesis of inflammatory bowel disease[J]. Nature, 2011, 474 (7351): 307- 317
doi: 10.1038/nature10209
|
4 |
KVHN R , L?HLER J , RENNICK D et al. Interleukin-10-deficient mice develop chronic enterocolitis[J]. Cell, 1993, 75 (2): 263- 274
doi: 10.1016/0092-8674(93)80068-P
|
5 |
RENNICK D M , FORT M M . Lessons from genetically engineered animal models. Ⅻ. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation[J]. Am J Physiol Gastrointest Liver Physiol, 2000, 278 (6): G829- G833
doi: 10.1152/ajpgi.2000.278.6.G829
|
6 |
VAN DER SLUIS M , DE KONING B A , DE BRUIJN A C et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection[J]. Gastroenterology, 2006, 131 (1): 117- 129
doi: 10.1053/j.gastro.2006.04.020
|
7 |
VAN DER SLUIS M , BOUMA J , VINCENT A et al. Combined defects in epithelial and immunoregulatory factors exacerbate the pathogenesis of inflammation:mucin 2-interleukin 10-deficient mice[J]. Lab Invest, 2008, 88 (6): 634- 642
doi: 10.1038/labinvest.2008.28
|
8 |
PODOLSKY D K . Inflammatory bowel disease[J]. N Engl J Med, 2002, 347 (6): 417- 429
doi: 10.1056/NEJMra020831
|
9 |
RUIZ P A , SHKODA A , KIM S C et al. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis[J]. J Immunol, 2005, 174 (5): 2990- 2999
doi: 10.4049/jimmunol.174.5.2990
|
10 |
FENTON J I , HURSTING S D , PERKINS S N et al. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line[J]. Carcinogenesis, 2006, 27 (7): 1507- 1515
doi: 10.1093/carcin/bgl018
|
11 |
NISHIYAMA T , MITSUYAMA K , TOYONAGA A et al. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease[J]. Digestion, 1994, 55 (6): 368- 373
doi: 10.1159/000201167
|
12 |
AKITSU A , KAKUTA S , SAIJO S et al. Rag2-deficient IL-1 receptor antagonist-deficient mice are a novel colitis model in which innate lymphoid cell-derived IL-17 is involved in the pathogenesis[J]. Exp Anim, 2014, 63 (2): 235- 246
doi: 10.1538/expanim.63.235
|
13 |
SHINKAI Y , RATHBUN G , LAM K P et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement[J]. Cell, 1992, 68 (5): 855- 867
doi: 10.1016/0092-8674(92)90029-C
|
14 |
HANSEN R , THOMSON J M , FOX J G et al. Could Helicobacter organisms cause inflammatory bowel disease?[J]. FEMS Immunol Med Microbiol, 2011, 61 (1): 1- 14
doi: 10.1111/fim.2011.61.issue-1
|
15 |
FOX J G , GE Z , WHARY M T et al. Helicobacter hepaticus infection in mice:models for understanding lower bowel inflammation and cancer[J]. Mucosal Immunol, 2011, 4 (1): 22- 30
doi: 10.1038/mi.2010.61
|
16 |
WARD J M , ANVER M R , HAINES D C et al. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus[J]. Lab Anim Sci, 1996, 46 (1): 15- 20
|
17 |
KULLBERG M C , WARD J M , GORELICK P L et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10(IL-10)-deficient mice through an IL-12-and gamma interferon-dependent mechanism[J]. Infect Immun, 1998, 66 (11): 5157- 5166
|
18 |
WEST N R , HEGAZY A N , OWENS B M J et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease[J]. Nat Med, 2017, 23 (5): 579- 589
|
19 |
SHEN Z , FENG Y , RICKMAN B et al. Helicobacter cinaedi induced typhlocolitis in Rag-2-deficient mice[J]. Helicobacter, 2015, 20 (2): 146- 155
doi: 10.1111/hel.2015.20.issue-2
|
20 |
BOIVIN M A , ROY P K , BRADLEY A et al. Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction[J]. J Interferon Cytokine Res, 2009, 29 (1): 45- 54
doi: 10.1089/jir.2008.0128
|
21 |
MA T Y , IWAMOTO G K , HOA N T et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation[J]. Am J Physiol Gastrointest Liver Physiol, 2004, 286 (3): G367- G376
doi: 10.1152/ajpgi.00173.2003
|
22 |
DIJKSTRA G , ZANDVOORT A J , KOBOLD A C et al. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease[J]. Scand J Gastroenterol, 2002, 37 (5): 546- 554
doi: 10.1080/00365520252903099
|
23 |
THELESTAM M , FRISAN T . Cytolethal distending toxins[J]. Rev Physiol Biochem Pharmacol, 2004, 152:111- 133
|
24 |
SHEN Z , FENG Y , ROGERS A B et al. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice[J]. Infect Immun, 2009, 77 (6): 2508- 2516
doi: 10.1128/IAI.00166-09
|
25 |
SAGAMI S , UENO Y , TANAKA S et al. Cholinedeficiency causes colonic type Ⅱ natural killer T (NKT) cell loss and alleviates murine colitis under type Ⅰ NKT cell deficiency[J]. PLoS One, 2017, 12 (1): e0169681
doi: 10.1371/journal.pone.0169681
|
26 |
DE WINTER B Y , VAN DEN WIJNGAARD R M , DE JONGE W J . Intestinal mast cells in gut inflammation and motility disturbances[J]. Biochim Biophys Acta, 2012, 1822 (1): 66- 73
doi: 10.1016/j.bbadis.2011.03.016
|
27 |
CHICHLOWSKI M , WESTWOOD G S , ABRAHAM S N et al. Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice[J]. PLoS One, 2010, 5 (8): e12220
doi: 10.1371/journal.pone.0012220
|
28 |
ZHU H , LI Y R . Oxidative stress and redox signaling mechanisms of inflammatory bowel disease:updated experimental and clinical evidence[J]. Exp Biol Med(Maywood), 2012, 237 (5): 474- 480
doi: 10.1258/ebm.2011.011358
|
29 |
ZHANG H , XUE Y , WANG H et al. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice[J]. World J Gastroenterol, 2014, 20 (27): 9106- 9615
|
30 |
MIZOGUCHI A , TAKEUCHI T , HIMURO H et al. Genetically engineered mouse models for studying inflammatory bowel disease[J]. J Pathol, 2016, 238 (2): 205- 219
doi: 10.1002/path.4640
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|